Behçet disease is a rare inflammatory condition that can affect the mouth, genitals, eyes, skin, joints, gut, and brain. People with Behçet disease often have repeated mouth sores, genital ulcers, eye redness or pain, skin bumps, and joint aches. It usually follows a relapsing course with flares and quiet periods, and it can start in young adulthood. Most people with Behçet disease live a normal lifespan, but vision loss or blood vessel problems can occur if inflammation is not controlled. Treatment for Behçet disease focuses on calming inflammation with topical medicines, colchicine, steroids, or immune‑modulating drugs, and regular follow‑up helps manage flares and protect eyesight.
Overview
Behçet diseaseSymptoms
Behçet disease often causes repeat painful mouth and genital sores, eye redness or blurred vision, and tender skin bumps. Many also have joint pain, fatigue, and headaches. Flares can involve the gut or brain and need prompt care.
Outlook and prognosis
Most people with Behçet disease have flare-ups that come and go, with quiet periods in between. With tailored care—often combining medicines, eye and dental checks, skin and joint care—many keep symptoms controlled and protect vision and organs. Outlook varies; earlier treatment of eye or blood vessel problems supports better long-term health.
Causes and risk factors
Behçet disease likely stems from an overactive immune response in genetically susceptible people, often linked to HLA-B51. Risk factors for Behçet disease include family history, Mediterranean/Middle Eastern/Asian ancestry, ages 20–40, and smoking. Infections and stress may trigger flares.
Genetic influences
Genetics plays a meaningful but not exclusive role in Behçet disease. Certain inherited variants (like HLA‑B51) raise risk, yet many with these variants never develop it. Family history can matter, but environment and immune triggers also contribute.
Diagnosis
Behçet disease is diagnosed by symptom patterns: recurrent mouth ulcers plus genital sores, eye inflammation, or skin changes. Doctors may use criteria, examine you, and order eye exams, blood tests, a pathergy test, or imaging for diagnosis of Behçet disease.
Treatment and drugs
Treatment for Behçet disease aims to calm flares, protect vision and organs, and maintain daily function. Plans often combine steroid creams or mouth rinses for sores, short courses of tablets for flares, and longer-term immune‑modulating medicines. Eye or organ involvement may need biologics and specialist care.
Symptoms
Behçet disease causes periods of inflammation that come and go, often affecting the mouth, skin, eyes, joints, and blood vessels. People often ask about early symptoms of Behçet disease; for many, it starts with painful mouth sores that return, sometimes along with skin bumps or eye irritation. These flares can interrupt eating, reading on bright screens, or walking comfortably, then settle for a while before returning. Symptoms vary from person to person and can change over time.
Painful, shallow ulcers inside the lips, cheeks, or tongue that come and go. They can make eating, drinking, and brushing uncomfortable. These are often among the first signs people notice.
Similar sores on the vulva, scrotum, or groin that may scar after healing. They can make sex, urination, or sitting uncomfortable. They tend to flare and then settle.
Red, painful eyes with blurred vision or sensitivity to light. In Behçet disease, this often reflects inflammation inside the eye (uveitis). Without prompt care, repeated flares can threaten sight.
Tender red bumps on the legs or acne-like breakouts on the face or trunk. Cuts or needle sticks can swell more than expected. These flares often leave the skin sore or bruised-looking.
How people usually first notice Behçet disease?
Many first notice Behçet disease when painful, recurring mouth sores appear—often mistaken for “canker sores” that heal and then return within weeks. Over time, patterns emerge: similar sores on the genitals, eye redness with light sensitivity or blurred vision, or tender, acne-like bumps on the skin, sometimes after minor needle sticks. For many, the “first signs of Behçet disease” are this combination of repeat ulcers and unexplained eye or skin inflammation, which prompts a visit to a clinician familiar with the condition.
Types of Behçet disease
Behçet disease can look different from one person to the next, and doctors sometimes describe patterns based on which body systems are most affected. People may notice different sets of symptoms depending on their situation. Some patterns are defined by eye inflammation, while others center on mouth and genital ulcers, skin changes, joint pain, or blood vessel involvement. Understanding these types of Behçet disease can help you and your care team track flares and plan treatment.
Mucocutaneous type
Mouth sores and genital ulcers lead the picture, often with acne-like bumps or tender red nodules on the legs. Flares can be frequent but may respond well to topical treatments or pills. Joint aches may come and go.
Ocular type
Eye inflammation causes pain, redness, blurred vision, or light sensitivity. Without prompt care, repeated flares can threaten vision. Regular eye checks help catch changes early.
Vascular type
Inflammation targets veins or arteries, leading to painful clots, limb swelling, or, less often, aneurysms. Symptoms may include chest pain, shortness of breath, or leg heaviness with activity. This type of Behçet disease usually needs specialist care and close monitoring.
Neurologic type
Brain or spine involvement can bring headaches, balance problems, weakness, or mood and thinking changes. Some may notice double vision or facial weakness during flares. Imaging and spinal fluid tests often guide treatment.
Gastrointestinal type
Inflammation in the bowel causes belly pain, diarrhea, or bleeding, sometimes resembling inflammatory bowel disease. People may have weight loss or anemia during active phases. Endoscopy can help confirm the pattern.
What genetics can tell you about symptoms
Some people with HLA-B51, a common genetic marker in Behçet disease, tend to have more frequent mouth and genital ulcers and eye inflammation. Variants affecting immune signaling (like IL10 or IL23R) can tilt the immune response, linking to more severe skin, joint, or gut flares.
Causes and risk factors
In Behçet disease the cause is unknown, and the immune system can misfire and inflame blood vessels. A family tendency increases risk, and a gene marker called HLA-B51 is linked to Behçet disease. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Suspected triggers include certain infections, smoking, stress, and minor injuries, like after dental work. Behçet disease is more common along the Mediterranean, the Middle East, and East Asia, and onset is most common in young adults.
Environmental and biological risk factors
Behçet disease is a relapsing inflammatory condition that affects blood vessels throughout the body. Understanding who is more likely to develop Behçet disease can help you notice early symptoms of Behçet disease sooner and seek care. That said, biology and environment work hand in hand. Here are the main body-based and exposure-related factors tied to higher likelihood.
Men have a higher chance of developing Behçet disease and may experience more severe vessel inflammation. Hormonal influences likely play a role. Women can be affected too.
Onset most often occurs between 20 and 40 years. This age window reflects a biological pattern seen across many countries. Cases can appear outside this range.
Living in or having roots in areas with higher rates, such as Turkey, the Middle East, East Asia, and North Africa, is linked to greater likelihood of Behçet disease. Shared infections and other regional exposures may contribute. Risk still varies within these regions.
Prior exposure to common mouth bacteria or certain viruses can trigger an outsized immune response. Most people with these exposures never develop Behçet disease. Flares may also follow recent infections.
Genetic risk factors
Behçet disease has a strong genetic component, centered on immune system genes that shape how the body handles inflammation. Carrying a genetic change doesn’t guarantee the condition will appear, but certain variants raise the chances. Knowing about these inherited factors can help families discuss early symptoms of Behçet disease and seek timely care.
HLA-B51 variant: The strongest known genetic risk for Behçet disease is a version of the HLA-B gene called HLA-B51. It guides how the immune system displays protein pieces, which can set the stage for inflammation.
Other HLA types: Several other class I HLA types, such as HLA-A26, also contribute to risk in some groups. Their effects are smaller than HLA-B51 and vary by ancestry.
ERAP1 interaction: Changes in ERAP1, a gene that trims proteins before loading them onto HLA, can raise risk, especially in people who carry HLA-B51. This gene-gene interaction may shape which fragments the immune system reacts to.
IL10 variants: Variants in the IL10 gene are linked to lower anti-inflammatory signals. With less braking, the chance of Behçet disease-related immune flares can increase.
IL23 pathway genes: Changes near IL23R and IL12RB2 affect the IL-23/Th17 pathway. These variants modestly increase susceptibility to Behçet disease.
STAT4 changes: Variants in STAT4, a signal switch for immune cells, have been associated with Behçet disease in multiple studies. They may make inflammatory responses more easily triggered.
Family history: Having a close relative with Behçet disease raises personal risk compared with the general population. This reflects shared genes rather than a single inherited cause.
Genetic ancestry: Behçet disease is more common among people with Turkish, Middle Eastern, Mediterranean, or East Asian ancestry, partly due to higher frequencies of risk genes like HLA-B51. Ancestry influences baseline risk but does not determine outcomes.
Polygenic profile: Most people with Behçet disease carry many small-effect variants across immune genes rather than one causative mutation. Together, this background nudges the immune system toward higher reactivity.
Monogenic mimics: Rare single-gene autoinflammatory conditions can cause Behçet-like symptoms but are distinct from Behçet disease. These include changes in inflammation-control genes and usually present in childhood.
Lifestyle risk factors
Lifestyle habits don’t cause Behçet disease, but they can influence flare frequency, symptom severity, and complications such as blood clots. Understanding lifestyle risk factors for Behçet disease can help you make day-to-day choices that better control symptoms. Small, tailored changes often have meaningful effects on comfort and function.
In people with Behçet disease, smoking is linked to more severe vascular and eye involvement. Quitting may reduce flare frequency and lower the risk of blood clots.
Psychological stress is frequently reported to precede flares. Stress-management practices may shorten flare duration and reduce ulcer recurrences.
Dental plaque and gum inflammation can trigger or worsen oral ulcers in Behçet disease. Gentle daily brushing and regular dental cleanings may reduce ulcer frequency.
Spicy, acidic, or rough-textured foods can aggravate mouth and genital ulcers and delay healing in Behçet disease. Identifying personal triggers and choosing softer, non-acidic options can ease symptoms during flares.
Risk prevention
You can’t fully prevent Behçet disease, but you can lower the chance of flares and complications by building steady, protective habits. Prevention is about lowering risk, not eliminating it completely. Regular care, early treatment of new symptoms, and attention to blood vessel health make the biggest difference over time.
See your rheumatology and eye specialists as advised. Ongoing exams can catch eye inflammation and other issues early.
Take medicines exactly as prescribed, and don’t stop suddenly unless your doctor says it’s safe. Keep a written plan for what to do at the first sign of a flare.
Stay up to date with routine vaccines; ask about timing if you take immune-suppressing drugs. Avoid live vaccines when on these medicines and practice good hand hygiene to reduce infections that can trigger flares.
Gentle daily mouth care and regular dental checkups may lower mouth-sore flares. Treat yeast or other infections quickly to reduce irritation and ulcer risk.
Transmission
Behçet disease is not contagious; you can’t catch it from someone or pass it on through coughing, kissing, sex, or sharing utensils. It isn’t spread by blood, and it doesn’t pass like an infection during pregnancy; it reflects an overactive immune system rather than a germ.
There is a genetic component—how Behçet disease is inherited is complex and not tied to a single gene—so it can cluster in families, but most children of a parent with Behçet disease will not develop it. Several immune-related genes may raise susceptibility, and environmental triggers likely play a role, which is why many people with Behçet disease have no family history.
When to test your genes
Behçet disease isn’t usually a genetic disorder, but genetic testing can help in select cases. Consider testing if you have recurrent mouth/genital ulcers, eye inflammation, or blood-vessel problems with a strong family history or early onset, to refine diagnosis and guide treatment. Discuss HLA-B*51 testing and targeted panels with your clinician.
Diagnosis
Behçet disease is usually identified by the pattern of symptoms that come and go, such as repeated mouth sores, genital ulcers, eye irritation, and skin bumps that can slow down daily routines. There isn’t a single test that confirms it; instead, providers look at how the features fit together over time. Doctors usually begin with a careful review of your symptoms and a focused exam before ordering tests to narrow down other causes. If you’re wondering how Behçet disease is diagnosed, it typically involves a mix of clinical evaluation and targeted tests.
Your provider reviews how often mouth sores, genital ulcers, eye symptoms, and skin changes occur. Patterns over months help separate Behçet disease from more common conditions. Keeping notes about flares can be useful.
The exam looks for current sores, skin bumps, joint swelling, or tender areas along blood vessels. Findings during a flare can be especially informative.
An eye specialist checks for inflammation inside the eye that can affect vision. Early eye findings support the diagnosis of Behçet disease and guide urgent treatment.
A tiny needle prick is placed on the skin to see if an exaggerated red bump forms within a day or two. A positive response supports Behçet disease, though not everyone shows it.
Stages of Behçet disease
Behçet disease does not have defined progression stages. Symptoms tend to flare and then settle, and different areas—mouth, skin, eyes, joints, blood vessels, or brain—may be involved at different times, so it doesn’t move in a straight line from mild to severe. Many first notice mouth sores as early symptoms of Behçet disease, but patterns vary widely from person to person. Different tests may be suggested to help piece together the diagnosis over time—doctors often track symptoms across visits, check the eyes regularly, use blood tests to rule out other causes, and order scans if blood vessels or the nervous system might be involved.
Outlook and prognosis
Looking ahead can feel daunting, but most people with Behçet disease can live full lives with the right plan and follow-up. Flare-ups tend to come and go. One year you might have frequent mouth ulcers and skin bumps; another year is quieter except for occasional eye irritation or joint pain. Everyone’s journey looks a little different. Some have mostly mucosal symptoms, while others deal with eye inflammation, blood-clot risks, or bowel involvement that needs closer monitoring.
Doctors call this the prognosis—a medical word for likely outcomes. With modern care, vision-threatening eye disease has dropped sharply, and many living with Behçet disease maintain day-to-day independence and work. Serious complications are uncommon but can include vision loss from untreated uveitis, clots in large veins, aneurysms in arteries, or central nervous system inflammation. Mortality is low overall in high-resource settings; when deaths occur, they’re usually linked to major blood vessel or brain involvement, which is why early symptoms of Behçet disease that affect the eyes, nerves, or chest should prompt urgent evaluation.
Early care can make a real difference, especially when flares are treated quickly and maintenance medicines are adjusted to prevent relapses. Over time, most people find their flare frequency decreases, particularly after the first 5–10 years, though some need long-term immune-modulating treatment to keep inflammation quiet. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including smoking status and how promptly flares are treated. Talk with your doctor about what your personal outlook might look like, including your organ involvement, response to treatment, and any risks that deserve extra monitoring.
Long-term effects
Living with Behçet disease can mean periods of calm interrupted by flares that affect the mouth, skin, eyes, joints, blood vessels, and sometimes the nervous system. Long-term effects vary widely, and they often depend on which areas are involved and how often inflammation returns. Many people remember the early symptoms of Behçet disease as painful mouth sores and tender skin bumps that come and go. Over time, some features may settle while others return in cycles, shaping day-to-day comfort, vision, mobility, and energy levels.
Painful mouth sores can recur over years and disrupt eating or speaking. They usually heal between flares but may leave lingering sensitivity.
Ulcers in the genital area can be deep and slow to heal. Scarring is common and may cause ongoing discomfort during intimacy or movement.
Repeated eye flares can cause blurred vision, light sensitivity, and eye pain. Over time, scarring inside the eye increases the risk of lasting vision loss.
Episodes of uveitis can lead to blind spots, floaters, or reduced sharpness. Frequent inflammation raises the chance of permanent damage to the retina or optic nerve.
How is it to live with Behçet disease?
Living with Behçet disease often means planning around unpredictability: flares can bring mouth or genital ulcers, eye inflammation, skin lesions, joint pain, and deep fatigue, then ease for a while before returning. Daily life may involve keeping up with medications, protecting the eyes and skin during flares, and pacing activities to prevent exhaustion, while staying alert for warning signs that need urgent care, like vision changes or severe headaches. Work, school, and social plans sometimes need flexibility, and the visible symptoms can affect confidence or intimacy, but clear communication and support—from partners, family, friends, employers, and clinicians—helps many people keep relationships strong and routines steady.
Treatment and drugs
Behçet disease treatment focuses on calming flares, protecting eyes and other organs, and easing day‑to‑day symptoms like mouth sores, skin lesions, joint pain, and fatigue. Doctors often start with topical gels or mouth rinses, short courses of anti‑inflammatory drugs, and colchicine for sores and joint pain; if eyes, brain, blood vessels, or intestines are involved, stronger medicines such as corticosteroids, immunosuppressants (like azathioprine, methotrexate, or cyclosporine), or biologics (such as anti‑TNF or interferon‑alpha) are used to prevent damage. Alongside medical treatment, lifestyle choices play a role, including gentle oral care, sun protection for skin, stopping smoking, staying up to date on vaccines, and planning rest during flares. A doctor may adjust your dose to balance benefits and side effects, and treatment intensity may change over time as symptoms wax and wane. If first-line treatments don’t help, specialists may try second-line options, and regular check-ins with ophthalmology, neurology, or rheumatology are key for people with eye or nervous system involvement.
Non-drug treatment
Living with Behçet disease often means managing flares that affect the mouth, skin, eyes, and joints in everyday life. Non-drug treatments often lay the foundation for comfort, function, and flare prevention alongside any prescriptions your care team recommends. Some people notice early symptoms of Behçet disease during stressful periods or after minor skin irritation, so small daily habits can matter. The options below focus on soothing symptoms, protecting sensitive areas, and supporting overall health.
Rinse with warm saltwater, use a soft toothbrush, and avoid spicy or acidic foods during flares. Petroleum jelly or a bland lip balm can shield sore areas from friction. Some strategies can slip naturally into your routine—like a gentle saltwater rinse after meals.
Clean with warm water, gently pat dry, and choose breathable, cotton underwear. Barrier products like plain petroleum jelly can reduce rubbing and discomfort. Sitz baths with lukewarm water may soothe pain.
Wear loose, soft fabrics and avoid tight straps that rub. Use a mild, fragrance-free cleanser and moisturize to reduce irritation. Cool compresses can ease tender bumps.
Behçet disease can inflame the eyes, medically known as uveitis, so protect them with sunglasses and use preservative-free artificial tears if dry. Seek urgent care for new floaters, light sensitivity, eye pain, or vision changes. Ask your doctor which warning signs need same-day attention.
Your genes may have an impact on how drugs work for you
Medicines for Behçet disease can work differently based on genes that affect how your body absorbs, breaks down, and clears drugs. Genetic differences may change dose needs or side‑effect risk, so clinicians sometimes adjust treatment or consider pharmacogenetic testing.
Pharmacological treatments
Medicines for Behçet disease aim to calm inflammation, ease symptoms like mouth ulcers and joint pain, and protect organs such as the eyes, brain, and blood vessels. Treatment is tailored to which areas are involved and how active the condition is, and it may change over time. Not everyone responds to the same medication in the same way. Options range from topical gels and eye drops to immune-suppressing tablets and biologic injections.
Steroid mouth gels or pastes (like triamcinolone) can soothe oral ulcers and help them heal faster. Steroid skin creams may ease genital sores and skin lesions. Steroid eye drops may be used for mild eye surface inflammation under specialist guidance.
Often used for painful mouth and genital ulcers and for joint pain or swelling. Many living with Behçet disease find it reduces the number and severity of these flares.
Ibuprofen or naproxen can reduce fever, pain, and stiffness during joint flares. These are symptomatic treatments and do not change the course of inflammation. They should be used cautiously if you have stomach, kidney, or heart risks.
Prednisone or similar tablets can quickly control severe flares affecting the eyes, blood vessels, brain, or many body areas. Dosing may be increased or lowered gradually to control symptoms while limiting side effects.
Genetic influences
Genes appear to shape who is more likely to develop Behçet disease, but they don’t tell the whole story. Family history is one of the strongest clues to a genetic influence. A well-known marker called HLA‑B51 can raise risk, especially in people with ancestry from countries along the old Silk Road (such as Turkey, the Middle East, and parts of East Asia), yet many with this marker never develop symptoms. Researchers have also found several other immune‑related genes that each add a small amount of risk, so this is likely due to many genes working together with environmental triggers rather than a single “Behçet gene.” Most people with Behçet disease have no close relative with it, and even when a parent is affected, the chance that a child will develop the condition remains relatively low. There isn’t a definitive genetic test for Behçet disease; HLA typing may add context about risk, but diagnosis still depends on your pattern of symptoms and exam findings over time.
Is Behçet disease genetic?
Genetics plays a meaningful but not exclusive role in Behçet disease. Certain inherited variants (like HLA‑B51) raise risk, yet many with these variants never develop it. Family history can matter, but environment and immune triggers also contribute.
Pharmacogenetics—how genetics influence drug effects
For people treated for Behçet disease, genes can sometimes guide medication choice and dosing. If your care plan includes azathioprine (a thiopurine), differences in genes called TPMT and NUDT15 can predict a much higher risk of severe low white blood cells; testing before or early in treatment helps set a safer starting dose or choose another medicine. Genetics is only one factor in how these medicines work; drug interactions, kidney and liver function, and the specific organs involved also play a big role. Colchicine is handled by liver enzymes and transport proteins, and while genetic differences may influence side effects, routine pharmacogenetic testing for colchicine isn’t recommended—your doctor will mainly manage this through dosing and avoiding interacting drugs. For cyclosporine or tacrolimus, which are occasionally used for eye or refractory disease, variations in CYP3A5 can affect how much drug you need, but regular blood level monitoring remains the standard approach. Response to biologics such as TNF blockers varies from person to person, yet no validated drug–gene test currently guides which biologic to choose in Behçet disease. HLA‑B51 increases the chance of developing Behçet disease, but on its own it doesn’t dictate treatment or predict which drug will work best.
Interactions with other conditions
Symptoms like mouth and genital ulcers, eye inflammation, and blood clots can overlap with problems seen in other illnesses, which can affect day-to-day treatment choices. Doctors call it a “comorbidity” when two conditions occur together. Behçet disease can mimic or coexist with inflammatory bowel disease; early symptoms of Behçet disease, such as repeated mouth sores and belly pain, may look like Crohn’s or ulcerative colitis flares, so getting the right match of medicines often needs a gastroenterology and rheumatology team. The illness also raises the chance of vein clots; if someone also has an inherited clotting tendency or antiphospholipid syndrome, blood-thinner decisions need careful balance, especially if lung artery bulges are present. Eye or brain inflammation may be confused with multiple sclerosis, and some treatments used for one condition can aggravate the other, so a neurologist’s input helps choose safe options. Because many people need immune-suppressing therapy, screening for infections like tuberculosis and hepatitis B, and using vaccines when appropriate (avoiding live vaccines during strong immune suppression), lowers risk. Estrogen-containing birth control, long travel, smoking, and heart or metabolic conditions can add to clot and vessel risks, so coordinated care looks at the whole picture.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described clusters of painful mouth sores, vision trouble, and skin bumps that came and went, often in young adults. In villages along old trade routes, some remembered a relative whose eyes became red and sensitive to light after bouts of ulcers. Others recalled leg sores that healed slowly, then flared again during stressful seasons. These everyday stories mirror what we now call Behçet disease.
First described in the medical literature as a triad of mouth ulcers, genital sores, and eye inflammation by the Turkish dermatologist Hulusi Behçet in 1937, the condition almost certainly existed long before. Early reports from regions spanning the Mediterranean to East Asia hinted at the same pattern, even if the language and emphasis differed. Some accounts focused on eye attacks that threatened sight; others on joint pain, skin nodules, or tender vein inflammation. Not every early description was complete, yet together they built the foundation of today’s knowledge.
With each decade, specialists broadened the picture. Doctors realized Behçet disease could affect blood vessels of many sizes, not just the eyes and mouth. This helped explain why some people developed clots in the legs, painful inflammation along veins, or, more rarely, problems in the brain or gut. As clinics compared notes across countries, they saw that symptoms varied by person and by region. For example, severe eye inflammation was often reported in parts of the Middle East and East Asia, while patterns elsewhere could look milder or different.
As medical science evolved, standard criteria were created to make diagnosis more consistent. The “pathergy” skin test—checking whether a small needle prick triggers an exaggerated skin reaction—was noted in many with Behçet disease, though it was never universal. Over time, descriptions became clearer about who is more likely to be affected: typically people in their 20s to 40s, with cases reported in all sexes and many ethnic backgrounds.
Advances in genetics added another layer. Researchers linked a specific immune marker, called HLA-B51, to increased risk in some populations, suggesting the immune system’s role and why Behçet disease clusters along certain ancestries and regions. Still, genetics is only part of the story, and having that marker doesn’t mean someone will develop the condition.
Treatment history moved from steroids alone to a wider set of options that calm an overactive immune response. Eye specialists and rheumatologists began working together to prevent flares and protect vision. More recently, targeted biologic medicines have helped many reduce relapses and maintain daily routines.
Looking back helps explain why Behçet disease can present in so many ways and why careful, whole-person care matters. Today’s approach—early recognition, coordinated treatment, and regular follow-up—grew from decades of observations across countries and clinics, turning scattered reports into practical guidance for living well with this condition.